Rho kinase (ROCK) inhibitors are potential therapeutic agents for the treatment of a variety of disorders including hypertension, glaucoma and erectile dysfunction. Here we disclose a series of potent and selective ROCK inhibitors based on a substituted 7-azaindole scaffold. Substitution of the 3-position of 7-azaindole led to compounds such as 37, which possess excellent ROCK inhibitory potency and high selectivity against the closely related kinase PKA.
Keywords: 7-Azaindole; Lipophilic efficiency; ROCK; Rho kinase; Solubilizing group; Structure-based design.
Copyright © 2018 Elsevier Ltd. All rights reserved.